𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

✍ Scribed by P. HARNETT; M. BUCK; P. BEALE; A. GOLDRICK; S. ALLAN; B. FITZHARRIS; P. De SOUZA; M. LINKS; G. KALIMI; T. DAVIES; R. STUART-HARRIS

Book ID
109085998
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
135 KB
Volume
17
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II and pharmacodynamic study of
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
✍ Edwin M. Posadas; Meghan S. Liel; Virginia Kwitkowski; Lori Minasian; Andrew K. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal‐transduction pathways in patients with recurrent epithelial ovarian cancer (EOC). The secondary objectives included assessing clinical activity and toxicity and d

A phase II study of gemcitabine in patie
A phase II study of gemcitabine in patients with malignant pleural mesothelioma
✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo